Skip to main content
SpringerLink
Log in

A decision to fund paclitaxel [Taxol] for node-positive early breast cancer from 1 September 2006 will give breast cancer treatments a boost in New Zealand,

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. PHARMAC.Breast cancer treatments get a funding boost. Media Release: 31 Aug 2006. Available from: URL: http://www.pharmac.govt.nz

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

A decision to fund paclitaxel [Taxol] for node-positive early breast cancer from 1 September 2006 will give breast cancer treatments a boost in New Zealand,. Pharmacoecon. Outcomes News 511, 10 (2006). https://doi.org/10.2165/00151234-200605110-00030

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605110-00030

Keywords

Search

Navigation